Search

Search Constraints

You searched for: Author/Creator Plimack, Elizabeth R

Search Results

1. Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial. Issue 9 (September 2016)

2. Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial. Issue 3 (March 2018)

3. Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study. Issue 4 (April 2019)

5. First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study. Issue 11 (November 2017)

8. Markers of inflammation are associated with clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab. (4th November 2015)

9. Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial. Issue 3 (March 2017)

10. Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial. Issue 6 (27th November 2020)